Skip to Content

Current Oncology, Volume 29, Issue 9

2022 September - 55 articles

Cover Story: Acute Myeloid Leukemia (AML) is an aggressive blood cancer with heterogeneous genomic drivers and a complex clonal structure at the time of diagnosis. Historically, the overall mortality associated with AML has been high; however, the prognosis for individual patients varies significantly and is primarily dependent on the baseline genetic risk and on response to therapy. In conjunction with the increasing knowledge of the genomics of AML, the therapeutic landscape has evolved significantly in recent times. Targeted treatments are now a mainstay of therapy for many patients in the frontline and relapsed/refractory setting. Newer treatments such as FLT3-inhibitors, BCL2-inhibitors and antibody-drug conjugates are improving outcomes for specific subsets of patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (55)

  • Case Report
  • Open Access
7 Citations
3,669 Views
10 Pages

Dealing with the Vicissitudes and Abject Consequences of Head and Neck Cancer: A Vital Role for Psycho-Oncology

  • Marco A. Mascarella,
  • Gregoire B. Morand,
  • Michael P. Hier,
  • Alexander Mlynarek,
  • Justine G. Albert,
  • David Kissane and
  • Melissa Henry

19 September 2022

Patients with head and neck cancer face important life-altering effects in appearance and function, affecting distress and quality of life and requiring the involvement of a multidisciplinary team. Psycho-oncology makes an important contribution to t...

  • Review
  • Open Access
18 Citations
4,776 Views
14 Pages

Immunogenic Cell Death Role in Urothelial Cancer Therapy

  • Reza Yadollahvandmiandoab,
  • Mehrsa Jalalizadeh,
  • Keini Buosi,
  • Herney Andrés Garcia-Perdomo and
  • Leonardo Oliveira Reis

18 September 2022

Purpose: Bladder cancer is the 13th most common cause of cancer death with the highest lifetime cost for treatment of all cancers. This scoping review clarifies the available evidence on the role of a novel therapeutic approach called immunogenic cel...

  • Article
  • Open Access
6 Citations
3,293 Views
12 Pages

18 September 2022

Acute myeloid leukemia (AML) is the most common type of hematological malignancy. Recently, an increasing number of reports have shown that many circular RNAs can act as effective targets for AML. However, the roles of circ_0059707 in AML remain larg...

  • Feature Paper
  • Review
  • Open Access
25 Citations
6,490 Views
14 Pages

17 September 2022

Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease....

  • Systematic Review
  • Open Access
5 Citations
4,161 Views
17 Pages

17 September 2022

Background: Existing data on adding internal mammary nodal irradiation (IMNI) to the regional nodal fields are inconsistent. Methods: Randomized trials investigating the addition of IMNI to standard adjuvant radiation were identified. Hazard ratios (...

  • Article
  • Open Access
3 Citations
3,359 Views
15 Pages

17 September 2022

Background: Primary central nervous system lymphoma (PCNSL) is a rare extranodal non-Hodgkin’s lymphoma that occurs in the central nervous system. Although sensitive to chemotherapy, 35–60% of PCNSL patients still relapse within 2 years a...

  • Article
  • Open Access
4 Citations
4,392 Views
7 Pages

Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program

  • Nicoletta Staropoli,
  • Elena Geuna,
  • Gaetana Rinaldi,
  • Giancarlo Bisagni,
  • Vieri Scotti,
  • Giovanni Faggioni,
  • Laura Vannini,
  • Carlo Arcara,
  • Gabriella Moretti and
  • Francesca Ragni
  • + 7 authors

17 September 2022

Ribociclib plus an aromatase inhibitor and ovarian function suppression is the preferred first-line option for pre-/perimenopausal women with hormone receptor-positive/human epidermal growth factor receptor-2-negative advanced or metastatic breast ca...

  • Case Report
  • Open Access
11 Citations
3,995 Views
7 Pages

Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy

  • Balázs Jóri,
  • Markus Falk,
  • Iris Hövel,
  • Peggy Weist,
  • Markus Tiemann,
  • Lukas C. Heukamp and
  • Frank Griesinger

16 September 2022

Lorlatinib, a third-generation anaplastic lymphoma kinase (ALK)/receptor tyrosine kinase inhibitor (ROS1), demonstrated efficacy in ROS1 positive (ROS1+) non-small cell lung cancer (NSCLC), although approval is currently limited to the treatment of A...

  • Systematic Review
  • Open Access
5 Citations
3,699 Views
18 Pages

16 September 2022

Fluoropyrimidine plus platinum (FP) and taxanes plus platinum (TP) are standard treatments for esophageal cancer (EC). This systematic review and meta-analysis aim to explore the difference in the therapeutic effect and toxicity of FP and TP regimens...

  • Feature Paper
  • Article
  • Open Access
8 Citations
4,106 Views
16 Pages

Evaluation of a Navigated 3D Ultrasound Integration for Brain Tumor Surgery: First Results of an Ongoing Prospective Study

  • Danilo Aleo,
  • Ziad Elshaer,
  • Andreas Pfnür,
  • Patrick J. Schuler,
  • Marco Maria Fontanella,
  • Christian Rainer Wirtz,
  • Andrej Pala and
  • Jan Coburger

15 September 2022

The aim of the study was to assess the quality, accuracy and benefit of navigated 2D and 3D ultrasound for intra-axial tumor surgery in a prospective study. Patients intended for gross total resection were consecutively enrolled. Intraoperatively, a...

  • Article
  • Open Access
10 Citations
4,944 Views
21 Pages

15 September 2022

Background: Colon adenocarcinoma (COAD) is the most common subtype of colon cancer, and cuproptosis is a recently newly defined form of cell death that plays an important role in the development of several malignant cancers. However, studies of cupro...

  • Article
  • Open Access
6 Citations
2,985 Views
9 Pages

Relationship between Salivary Amylase and Xerostomia in Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Pilot Study

  • Francesca De Felice,
  • Maria Giulia Scarabelli,
  • Raffaella De Pietro,
  • Giuseppina Chiarello,
  • Federico Di Giammarco,
  • Carlo Guglielmo Cattaneo,
  • Giuliana Lombardo,
  • Francesca Romana Montinaro,
  • Miriam Tomaciello and
  • Vincenzo Tombolini
  • + 5 authors

15 September 2022

Purpose. A single-institution prospective pilot study was conducted to the assess correlation between salivary amylase and xerostomia in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiotherapy (IMRT)....

  • Review
  • Open Access
11 Citations
3,655 Views
13 Pages

14 September 2022

Pancreatic cancer is associated with a poor prognosis. While surgical resection is the only treatment option with curative intent, most patients die of locoregional and/or distant recurrence. The prognostic impact of the resection margin status has r...

  • Article
  • Open Access
3 Citations
2,950 Views
11 Pages

Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series

  • Ahmed Habib,
  • Idara Edem,
  • Diana Bell,
  • Shirley Y. Su,
  • Ehab Y. Hanna,
  • Michael E. Kupferman,
  • Franco DeMonte and
  • Shaan M. Raza

14 September 2022

Soft tissue sarcomas (STS) invading the skull base are rare with little data to guide surgical management. Here we aimed to determine the factors affecting tumor control rates and survival in patients with T4 stage head and neck STS involving the sku...

  • Review
  • Open Access
32 Citations
6,574 Views
17 Pages

PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer

  • Danyu Ma,
  • Ying Zhang,
  • Xiaoliang Shao,
  • Chen Wu and
  • Jun Wu

11 September 2022

A portion of gastric cancer patients with negative lymph node metastasis at an early stage eventually die from tumor recurrence or advanced metastasis. Occult lymph node metastasis (OLNM] is a potential risk factor for the recurrence and metastasis i...

  • Article
  • Open Access
8 Citations
4,245 Views
15 Pages

10 September 2022

The Raf-MEK-ERK signaling network has been the subject of intense research due to its role in the development of human cancers, including pediatric neuroblastoma (NB). MEK and ERK are the central components of this signaling pathway and are attractiv...

  • Article
  • Open Access
16 Citations
3,596 Views
12 Pages

10 September 2022

Background: Neoadjuvant chemotherapy is important to improve the prognosis of patients with advanced gastric cancer. However, it may result in postoperative complications (POCs). The aim of this study is to evaluate risk factors and prognostic impact...

  • Article
  • Open Access
2 Citations
2,693 Views
11 Pages

Towards a Postgraduate Oncology Training Model for Family Medicine: Mixed Methods Evaluation of a Breast Oncology Rotation

  • Michelle B. Nadler,
  • Brooke E. Hofbauer,
  • Melinda Wu,
  • Susan Hum,
  • Christine Elser and
  • Joyce Nyhof-Young

10 September 2022

Background: Family physicians have low knowledge and preparedness to manage patients with cancer. A breast oncology clinical rotation was developed for family medicine residents to address this gap in medical education. Objectives and Methods: A brea...

  • Feature Paper
  • Article
  • Open Access
9 Citations
2,641 Views
13 Pages

A Study of Peripheral Blood Parameters to Predict Response to Induction Chemotherapy and Overall Survival in Advanced Laryngeal Squamous Cell Carcinoma

  • Jiaqi Xu,
  • Yifan Yang,
  • Qi Zhong,
  • Lizhen Hou,
  • Hongzhi Ma,
  • Yang Zhang,
  • Ling Feng,
  • Shizhi He,
  • Meng Lian and
  • Ru Wang
  • + 1 author

9 September 2022

Purpose: the purpose of this study was to screen peripheral blood parameters and construct models predicting the prognosis and induction chemotherapy (IC) response in locally advanced laryngeal squamous cell carcinoma (LSCC) patients. Methods: A tota...

  • Article
  • Open Access
18 Citations
3,173 Views
9 Pages

Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis

  • Young Il Kim,
  • Ja Young Shin,
  • Seung Ho Yang,
  • Hyun Ho Kim,
  • Byoung Yong Shim and
  • Stephen Ahn

8 September 2022

Temporal muscle thickness (TMT) has recently been suggested as a novel biomarker of sarcopenia in head and neck malignancies. However, few studies have evaluated TMT as a prognostic marker in patients with brain metastasis. This study investigated th...

  • Review
  • Open Access
17 Citations
4,163 Views
18 Pages

A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma

  • Angelica Singh,
  • Sofia Zahid,
  • Ilya Noginskiy,
  • Timothy Pak,
  • Soeb Usta,
  • Marina Barsoum and
  • Uqba Khan

8 September 2022

Hepatocellular carcinoma remains a leading cause of cancer-related deaths worldwide. Liver disease including cirrhosis and viral hepatitis remains among the leading causes of hepatocellular carcinoma and despite increased screening, many patients are...

  • Review
  • Open Access
2 Citations
4,950 Views
12 Pages

Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done

  • Marzia Mare,
  • Lorenzo Memeo,
  • Cristina Colarossi and
  • Dario Giuffrida

8 September 2022

In recent years, advances of anticancer and supportive therapies have determined a gradual improvement in survival rates and patients’ general conditions in metastatic gastric cancer (mGC), allowing them to receive further treatments. The choic...

  • Review
  • Open Access
2 Citations
3,663 Views
14 Pages

8 September 2022

Cancer-associated venous thromboembolism is a devastating complication of cancer and is associated with significant morbidity and mortality. The cornerstone of cancer-associated venous thromboembolism treatment is anticoagulation, and in recent years...

  • Review
  • Open Access
28 Citations
11,320 Views
19 Pages

7 September 2022

Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumors are malignant. The most common sarcomas in the retroperitoneum include liposarcomas and leiomyosarcoma, however other sarcomas, along with benign m...

  • Article
  • Open Access
7 Citations
3,342 Views
17 Pages

Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity

  • Shinji Tsukamoto,
  • Andreas F. Mavrogenis,
  • Suraj Hindiskere,
  • Kanya Honoki,
  • Akira Kido,
  • Hiromasa Fujii,
  • Tomoya Masunaga,
  • Yasuhito Tanaka,
  • Pramod S. Chinder and
  • Costantino Errani
  • + 1 author

5 September 2022

En bloc resection is typically performed to treat giant cell tumors of bone (GCTB), particularly when curettage can be challenging owing to extensive bone cortex destruction with soft tissue extension. Few reports have addressed the clinical outcomes...

  • Article
  • Open Access
2 Citations
3,570 Views
10 Pages

The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)

  • Jiazhou Liu,
  • Shihang Pan,
  • Liang Dong,
  • Guangyu Wu,
  • Jiayi Wang,
  • Yan Wang,
  • Hongyang Qian,
  • Baijun Dong,
  • Jiahua Pan and
  • Wei Xue
  • + 1 author

5 September 2022

To explore the diagnostic value of the Prostate Imaging–Reporting and Data System version 2.1 (PI-RADS v2.1) for clinically significant prostate cancer (CSPCa) in patients with a history of transurethral resection of the prostate (TURP), we con...

  • Case Report
  • Open Access
7 Citations
6,022 Views
9 Pages

4 September 2022

Coexistent growing teratoma syndrome (GTS) and gliomatosis peritonei (GP) arising during chemotherapy of ovarian immature teratoma (IMT) is extremely rare and can be misdiagnosed as recurrent or progressive disease. We present a 33-year-old woman dia...

  • Review
  • Open Access
8 Citations
4,414 Views
14 Pages

The Impact of Exercise on Cardiotoxicity in Pediatric and Adolescent Cancer Survivors: A Scoping Review

  • Stephanie J. Kendall,
  • Jodi E. Langley,
  • Mohsen Aghdam,
  • Bruce N. Crooks,
  • Nicholas Giacomantonio,
  • Stefan Heinze-Milne,
  • Will J. Johnston,
  • Melanie R. Keats,
  • Sharon L. Mulvagh and
  • Scott A. Grandy

3 September 2022

Childhood and adolescent cancer survivors are disproportionately more likely to develop cardiovascular diseases from the late effects of cardiotoxic therapies (e.g., anthracycline-based chemotherapy and chest-directed radiotherapy). Currently, dexraz...

  • Article
  • Open Access
9 Citations
2,897 Views
8 Pages

2 September 2022

Concurrent chemoradiotherapy (CRT) is regarded as the standard treatment for inoperable esophageal cancers (EC). It is still controversial whether consolidation chemotherapy (CCT) or induction chemotherapy (IC) is beneficial for the patients who rece...

  • Case Report
  • Open Access
1 Citations
3,422 Views
8 Pages

1 September 2022

Carcinoma ex pleomorphic adenoma (Ca ex PA) is a rare malignant tumor that arises from a primary or recurrent benign pleomorphic adenoma (PA). Ca ex PA has an aggressive behavior and poor prognosis. To date, there are no standardized therapeutic meth...

  • Review
  • Open Access
1 Citations
3,420 Views
9 Pages

1 September 2022

Smoking cessation represents an untapped resource for cancer therapy. Many people who smoke and have cancer (tobacco-related or otherwise) struggle to quit and as a result, jeopardise response to treatment, recovery after surgery and long-term surviv...

  • Article
  • Open Access
6 Citations
3,300 Views
11 Pages

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer

  • Christoph Oehler,
  • Nina Roehner,
  • Marcin Sumila,
  • Jürgen Curschmann,
  • Fabrizio Storelli,
  • Daniel Rudolf Zwahlen and
  • Uwe Schneider

31 August 2022

Purpose: Determine the time-dependent magnitude of intrafraction prostate displacement and a cutoff for the tracking decision. Methods: Nine patients with localized prostate cancer were treated with ultra-hypofractionated radiotherapy (CyberKnife) wi...

  • Article
  • Open Access
14 Citations
3,390 Views
11 Pages

Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study

  • Sweet Ping Ng,
  • Carlos E. Cardenas,
  • Houda Bahig,
  • Baher Elgohari,
  • Jihong Wang,
  • Jason M. Johnson,
  • Amy C. Moreno,
  • Shalin J. Shah,
  • Adam S. Garden and
  • Clifton D. Fuller
  • + 11 authors

31 August 2022

Background: The PREDICT-HN study aimed to systematically assess the kinetics of imaging MR biomarkers during head and neck radiotherapy. Methods: Patients with intact squamous cell carcinoma of the head and neck were enrolled. Pre-, during, and post-...

  • Article
  • Open Access
17 Citations
4,761 Views
16 Pages

31 August 2022

In recent years, the incidence and mortality rates of cervical cancer (CC) have increased among young women. Cervical cancer screening (CCS) is crucial to reducing the incidence and mortality of CC in a country such as Japan, where it is challenging...

  • Article
  • Open Access
8 Citations
3,437 Views
10 Pages

The Art of Counseling in the Treatment of Head and Neck Cancer: Exploratory Investigation among Perceptions of Health Professionals in Southern Italy

  • Raffaele Addeo,
  • Luca Pompella,
  • Pasquale Vitale,
  • Silvia Ileana Sara Fattoruso,
  • Ilaria Di Giovanni,
  • Francesco Perri,
  • Michele Caraglia,
  • Morena Fasano and
  • Raffaele Arigliani

31 August 2022

(1) Background: Recurrent and/or metastatic patients with head and neck squamous cell carcinoma show a poor prognosis, which has not changed significantly in 30 years. Preserving quality of life is a primary goal for this subset of patients; (2) Meth...

  • Review
  • Open Access
21 Citations
6,670 Views
17 Pages

Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer

  • Lucy K. Corke,
  • Janice J. N. Li,
  • Natasha B. Leighl and
  • Lawson Eng

30 August 2022

Tobacco is a known risk factor for lung cancer, and continued tobacco use is associated with poorer outcomes across multiple lung cancer treatment modalities including surgery, chemotherapy and radiation therapy. Less is known about the association o...

  • Review
  • Open Access
92 Citations
18,004 Views
15 Pages

Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology

  • Ryan J. Stubbins,
  • Annabel Francis,
  • Florian Kuchenbauer and
  • David Sanford

30 August 2022

Acute myeloid leukemia (AML) is a hematologic malignancy that most frequently develops in older adults. Overall, AML is associated with a high mortality although advancements in genetic risk stratification and new treatments are leading to improvemen...

  • Article
  • Open Access
4 Citations
2,990 Views
9 Pages

Spinal Lesions as Clinical Manifestations of Plasma Cell Neoplasia

  • Lea Baumgart,
  • Melanie Barz,
  • Claire Delbridge,
  • Amir Kaywan Aftahy,
  • Insa Katrin Janssen,
  • Philipp J. Jost,
  • Yu-Mi Ryang,
  • Bernhard Meyer and
  • Jens Gempt

29 August 2022

(1) Background: Plasma cell neoplasia can be separated into independent subtypes including multiple myeloma (MM) and solitary plasmacytoma of the bone (SBP). The first clinical signs patients present with are skeletal pain, most commonly involving ri...

  • Article
  • Open Access
3 Citations
2,323 Views
10 Pages

29 August 2022

(1) Background: The coronavirus 2019 pandemic has resulted in an abrupt transition to virtual oncology care worldwide. This study’s objective is to evaluate chemotherapy delivery and clinical outcomes in patients on systemic treatment for color...

  • Review
  • Open Access
10 Citations
4,004 Views
15 Pages

29 August 2022

There is growing evidence supporting the substantial, essential and indispensable role of endoscopic ultrasound (EUS) as a key diagnostic armamentarium for upper GI oncologic surgery. Well described in countless publications, EUS holds that position...

  • Case Report
  • Open Access
1 Citations
4,497 Views
8 Pages

29 August 2022

Durvalumab consolidation therapy is the standard treatment after concurrent chemoradiotherapy for patients with surgically unresectable stage IIIA (N2) non-small-cell lung cancer (NSCLC). Neoadjuvant therapy followed by surgery could reduce locoregio...

  • Article
  • Open Access
8 Citations
3,749 Views
17 Pages

Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial

  • Anouk S. Schuit,
  • Karen Holtmaat,
  • Veerle M. H. Coupé,
  • Simone E. J. Eerenstein,
  • Josée M. Zijlstra,
  • Corien Eeltink,
  • Annemarie Becker-Commissaris,
  • Lia van Zuylen,
  • Myra E. van Linde and
  • Femke Jansen
  • + 11 authors

27 August 2022

Evidence on the cost-effectiveness of eHealth in palliative care is scarce. Oncokompas, a fully automated behavioral intervention technology, aims to support self-management in cancer patients. This study aimed to assess the cost-utility of the eHeal...

  • Article
  • Open Access
2 Citations
3,289 Views
9 Pages

26 August 2022

Background: The COVID-19 pandemic has significantly altered the lives of pediatric oncology social workers. Challenges include difficulty building rapport with the use of telephone/computers, lack of clarity around who is designated as “essenti...

  • Article
  • Open Access
14 Citations
5,236 Views
10 Pages

Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis

  • Munzir Hamid,
  • Michelle Hannan,
  • Nay Myo Oo,
  • Paula Lynch,
  • Darren J. Walsh,
  • Tara Matthews,
  • Stephen Madden,
  • Miriam O’Connor,
  • Paula Calvert and
  • Anne M. Horgan

26 August 2022

The Comprehensive Geriatric Assessment (CGA) is recommended to guide treatment choices in older patients with cancer. Patients ≥ 70 years referred to our oncology service with a new cancer diagnosis are screened using the G-8. Patients with a scor...

  • Article
  • Open Access
9 Citations
2,658 Views
13 Pages

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer

  • Bin Shao,
  • Xiaoran Liu,
  • Huiping Li,
  • Guohong Song,
  • Lijun Di,
  • Hanfang Jiang,
  • Ying Yan,
  • Ruyan Zhang,
  • Ran Ran and
  • Jing Wang
  • + 3 authors

25 August 2022

This study aimed to examine the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and other clinicopathological features in HER2+ MBC patients who received first-line anti-HER2 therapy. A total of 129 patients were assigned to NLR-low and...

  • Systematic Review
  • Open Access
28 Citations
7,536 Views
17 Pages

The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Shi-Yu Ye,
  • Jia-Yi Li,
  • Teng-Hui Li,
  • Yong-Xi Song,
  • Jing-Xu Sun,
  • Xiao-Wan Chen,
  • Jun-Hua Zhao,
  • Yuan Li,
  • Zhong-Hua Wu and
  • Xuan-Zhang Huang
  • + 1 author

25 August 2022

The purpose of this meta-analysis was to evaluate the efficacy and safety of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, in addition to standard anticancer therapy. Randomized controlled trials (RCTs) that evaluated the efficacy and sa...

  • Article
  • Open Access
4 Citations
2,649 Views
12 Pages

25 August 2022

Background: Previously, research has reported associations of lipid and lipoprotein imbalances with carcinogenesis and cancer progression, so they have been considered as promising prognostic biomarkers for cancer in recent years. However, the correl...

  • Brief Report
  • Open Access
4 Citations
2,948 Views
10 Pages

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma

  • Emilio Bellitti,
  • Pierluigi Masciopinto,
  • Pellegrino Musto,
  • Elena Arcuti,
  • Luca Mastracci,
  • Giuseppina Opinto,
  • Sabino Ciavarella,
  • Attilio Guarini,
  • Gerardo Cazzato and
  • Giuseppe Ingravallo
  • + 3 authors

25 August 2022

The metachronic onset of diffuse large B-cell lymphoma (DLBCL) after classic Hodgkin lymphoma (cHL) is a rare event affecting patients’ outcomes. However, although several studies have investigated the prognostic role of this event, little is k...

  • Review
  • Open Access
72 Citations
12,190 Views
24 Pages

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention

  • Wenqian Li,
  • Tiantian Zhao,
  • Dacheng Wu,
  • Jiajia Li,
  • Mei Wang,
  • Yunyun Sun and
  • Sicong Hou

25 August 2022

Patients with ulcerative colitis (UC) are at a two- to three-fold increased risk of developing colorectal cancer (CRC) than the general population based on population-based data. UC-CRC has generated a series of clinical problems, which are reflected...

  • Article
  • Open Access
3 Citations
3,132 Views
14 Pages

Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study

  • Aristotelis Bamias,
  • Kimon Tzannis,
  • Roubini Zakopoulou,
  • Minas Sakellakis,
  • John Dimitriadis,
  • Alkistis Papatheodoridi,
  • Loukianos Rallidis,
  • Panagiotis Halvatsiotis,
  • Anna Tsiara and
  • Meletios-Athanasios Dimopoulos
  • + 20 authors

24 August 2022

Arterial thromboembolism has been associated with cancer or its treatment. Unlike venous thromboembolism, the incidence and risk factors have not been extensively studied. Here, we investigated the incidence of arterial thromboembolic events (ATEs) i...

of 2

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729